Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
November 2, 2010
Patent Application Number
10994712
Date Filed
November 22, 2004
Patent Primary Examiner
Patent abstract
Ophthalmically acceptable compositions used in arresting the development of macular degeneration, retinopathy, glaucoma, eyelid disorders, corneal disease, or uveitis are disclosed. The compositions comprise a pharmaceutically acceptable carrier or diluent and at least one compound having the formula:
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
